Not applicable(observational study)
Sponsors
Kang Stem Biotech Co., Ltd.
Conditions
Atopic DermatitisRheumatoid Arthritis
Unknown Phase
Evalution the Safety and Efficacy in Atopic Dermatitis Patients
NCT03962387
Start: 2019-04-05End: 2024-01-02Updated: 2021-06-16
Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients
NCT04087863
Start: 2019-08-29End: 2024-12-31Target: 99Updated: 2019-09-12
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
RecruitingNCT04134169
Start: 2019-10-02End: 2026-04-11Target: 28Updated: 2022-10-10
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Not yet recruitingNCT04730024
Start: 2022-03-27End: 2030-06-30Target: 102Updated: 2021-01-29